Cost-minimization Analysis on 3 Varieties of Antihistamines for Chronic Idiopathic Urticaria
- VernacularTitle:3种抗组胺药治疗慢性特发性荨麻疹的最小成本分析
- Author:
Jianmei PENG
;
Yuanhuan LIU
;
Hong LI
- Publication Type:Journal Article
- Keywords:
Chronic idliopathic urticaria;
Mizolastine;
Cetirizine;
Loratatine;
Cost-minimization analysis
- From:
China Pharmacy
1991;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE: To evaluate the therapeutic efficacy and pharmacoeconomic results of 3 varieties antihistamines in the treatment of chronic idiopathic urticaria. METHODS: 96 patients with idiopathic urticaria were randomly divided into Group A, B and C, treated with mizolastine ,cetirizine and loratatine for 28 days, respectively. The therapeutic effects and recurrence within 7 days after drug withdrawl were observed, and the results were analyzed using cost-minimization analysis. RESULTS: The effective rates in Group A, B, and C were 96.7%, 94.1% and 93.8%, respectively. The recurrent rates within 7 days after discontinuation of the treatment were 40.0%, 35.3% and28.1%, respectively . The cost of drugs were 116.76 yuan, 45.64 yuan and 128.8 yuan, respectively. CONCLUSION: Cetirizine is the preferable treatment prescription for idiopathic urticaria
